Earum Pharmaceuticals Rights Issue will open for subscription from 02 May 2023. the company aims for an issue size of ₹49.34 Crores through this rights Issue.
About the company
Incorporated in 2012, Earum Pharmaceuticals Limited is engaged in the pharmaceutical business involving marketing, trading, and distribution of pharmaceutical formulation products. Earum Pharmaceuticals’ product range includes anti-biotic drugs, anti-malarial drugs, anti-allergic & anti-cold drugs, analgesic/antipyretic & anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, anti-oxidants, and injections. Currently, the company has its presence in Indian States such as Gujarat, Maharashtra, Chhattisgarh, Uttar Pradesh, Mizoram, Andhra Pradesh, Rajasthan, Madhya Pradesh, Manipur, Assam, Meghalaya, Kerala, Telangana, etc., and intends to penetrate international markets as well.
Objectives of the Issue
- For working capital requirements.
- Repayment of loan.
- General corporate purposes.
Rights Issue Timetable
| Last Date to buy shares | 06 April 2023 |
| Record Date | 10 April 2023 |
| Credit of Rights Entitlements | 26 April 2023 |
| Bid/Offer Opens On | 02 May 2023 |
| Renunciation of Rights Entitlements | 26 May 2023 |
| Bid/Offer Closes On | 31 May 2023 |
| Deemed Date of Allotment | 10 June 2023 |
| Credit Date | 16 June 2023 |
| Listing Date | 20 June 2023 |
Rights Issue Details
| Issue Open | May 2, 2023 – May 31, 2023 |
| Security Name | Earum Pharmaceuticals Limited |
| Issue Size (Shares) | 246,716,400 |
| Issue Size (Amount) | ₹49.34 Crores |
| Issue Price | ₹2 per share |
| Face Value | ₹2 per share |
| Listing At | BSE |
| Terms of Payment | Investors will have to pay Rs. 0.50 at the time of allotment, Rs. 0.50 at the time of 1st Call, Rs. 0.50 at the time of 2nd Call and Rs. 0.50 at the time of 3rd and Final Call. |
| Entitlement | 4 Equity Shares for every 1 Equity Shares held on the Record Date |
Company Financials
| Period Ended | Total Assets | Total Revenue | Profit After Tax | Reserves and Surplus |
|---|---|---|---|---|
| 31-Mar-20 | 36.16 | 57.38 | 1.82 | 8.25 |
| 31-Mar-21 | 27.87 | 50.02 | 0.09 | 8.33 |
| 31-Mar-22 | 28.79 | 28.74 | 2.22 | 4.39 |
Rights Issue Documents
Lead Manager(s)
- Axis Bank Limited
Rights Issue Registrar
Bigshare Services Pvt Ltd
Phone: +91-22-6263 8200
Email: rightsissue@bigshareonline.com
Website: https://www.bigshareonline.com/
Company Contact Information
Earum Pharmaceuticals Limited
A-1106, Empire Business Hub,
Near AUDA Water Tank, Science City Road,
Sola, Ahmedabad – 380060
Phone: (079)-48402525
Email: cs@earumpharma.com
Website: http://www.earumpharma.com
Final Thoughts
Applying for the rights issue is purely a personal choice. make sure you make a detailed study about the company and rights issue before you make an investment decision.
Happy investing
